RH Reality Check
Font Size: A |  A |  A

Human Papiloma Virus

Colombia Fails to Include HPV Vaccine in Public Health System

By Angela Castellanos, RH Reality Check, Latin America

January 13, 2009 - 8:00am

Angela Castellanos's picture
In Colombia, a bill that would introduce the vaccine into Bogotá's public health care system has just failed for the third time.

. . . . .

Roundup: Abortion Has No Long-Term Effect on Mental Health; Allergic Reactions to Gardasil Uncommon

By Emily Douglas

December 4, 2008 - 11:14am

Emily Douglas's picture
Abortion has no effect on long-term mental health; Clinton's likely priorities as Secretary of State; allergic reactions to Gardasil uncommon; what effect would HHS conscience regulations have?

. . . . .

RH Reality Check Interviews Nobel Prizewinner Herald zur Hausen

By Lindsay Beyerstein, RH Reality Check

November 24, 2008 - 8:00am

Lindsay Beyerstein's picture
Prof. Herald zur Hausen's Nobel Prize-winning research paved the way for the first vaccine against cancer in medical history, the HPV vaccine.

. . . . .

Nobel Prize Awarded to Virologist Who Linked HPV to Cervical Cancer

By Lindsay Beyerstein, RH Reality Check

October 21, 2008 - 7:00am

Lindsay Beyerstein's picture
German virologist Harold zur Hausen’s Nobel Prize is a reminder that there is overwhelming scientific consensus that HPV is the cause of cervical cancer.

. . . . .

Inaccurate Pap Smear Results Common in Colombia

By Angela Castellanos, RH Reality Check, Latin America

October 1, 2008 - 7:00am

Angela Castellanos's picture
A majority of Colombian women get Pap smears, but new studies show that ten percent of such tests administered in Colombia yield inaccurate results.

. . . . .

HPV Vaccine Access Should Be Unrestricted

By Alexa Stanard, New Journalist Fellow

February 25, 2008 - 8:46am

Alexa Stanard's picture

A new study has found that administering the HPV vaccine based on a woman's risk factors could prevent access for the vast majority of eligible women. The study supports a federal recommendation that all females ages 11 to 26 should get the vaccine.


. . . . .